Prevention of lethal respiratory vaccinia infections in mice with interferon-alpha and interferon-gamma (Q47899338)

6 February 2018

title

Prevention of lethal respiratory vaccinia infections in mice with interferon-alpha and interferon-gamma (English)

1 reference

6 February 2018

author name string

Ge Liu

1

1 reference

6 February 2018

Qingzhu Zhai

2

1 reference

6 February 2018

Dustin J Schaffner

3

1 reference

6 February 2018

Aiguo Wu

4

1 reference

6 February 2018

Adiamseged Yohannes

5

1 reference

6 February 2018

Tanisha M Robinson

6

1 reference

6 February 2018

Matt Maland

7

1 reference

6 February 2018

Jay Wells

8

1 reference

6 February 2018

Thomas G Voss

9

1 reference

6 February 2018

Charlie Bailey

10

1 reference

6 February 2018

Ken Alibek

11

1 reference

6 February 2018

publication date

1 April 2004

1 reference

6 February 2018

FEMS Immunology and Medical Microbiology

published in

1 reference

6 February 2018

volume

40

1 reference

6 February 2018

issue

3

1 reference

6 February 2018

page(s)

201-206

1 reference

6 February 2018

Smallpox as a Biological Weapon

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Immune defence in mice lacking type I and/or type II interferon receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Immune response in mice that lack the interferon-gamma receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Current and evolving therapies for hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Chemotherapeutic prevention of complications caused by vaccinia virus-vectored immunogen

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Preparation of cell cultures and vaccinia virus stocks.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Tribromoethanol (Avertin) as an anaesthetic in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Interferon-alpha protects mice against lethal infection with St Louis encephalitis virus delivered by the aerosol and subcutaneous routes

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Pegylated alpha interferon is an effective treatment for virulent venezuelan equine encephalitis virus and has profound effects on the host immune response to infection

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Systemic effects of orally administered interferons and interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Simple mixing of IFN with a polysaccharide having high liver affinity enables IFN to target to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Lack of a Role for Type I and Type II Interferons in the Resolution of Rotavirus-Induced Diarrhea and Infection in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Viruses and interferon: a fight for supremacy

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Reduced mortality in murine cytomegalovirus infected mice following prophylactic murine interferon-gamma treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-infected mice with anti-interferon-gamma monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Acquired immunity of A/J mice to mouse hepatitis virus 3 infection: dependence on interferon- synthesis and macrophage sensitivity to interferon-

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

In vivo depletion of interferon-gamma leads to susceptibility of A/J mice to mouse hepatitis virus 3 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Recombinant Human Interferon-γ Modulates Rift Valley Fever Virus Infection in the Rhesus Monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Exogenous interferon-gamma induces endogenous synthesis of interferon-alpha and -beta by murine macrophages for induction of nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0928-8244%2803%2900358-4

7 January 2021

10.1016/S0928-8244(03)00358-4

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018